Abstract LB-138: Adjuvant pembrolizumab or placebo in patients with high-risk, locally advanced cutaneous squamous cell carcinoma: Phase 3 KEYNOTE-630

Authors: Anne Lynne S. Chang, Gregory A. Daniels, Ezra E. Cohen, Joy Yang Ge, Burak Gumuscu, Ramona F. Swaby, Jessica L. Geiger

Published: 2020-09-04

DOI: 10.1158/1538-7445.am2020-lb-138

Source: Full article